Items where authors include "Aljurf, M."

Article

Drozd-Sokołowska, J. orcid.org/0000-0002-4562-6264, Tridello, G., Verheggen, I. orcid.org/0000-0001-7749-5994 et al. (37 more authors) (2025) Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the infectious diseases working party of the EBMT. Bone Marrow Transplantation. ISSN 0268-3369

Garderet, L. orcid.org/0000-0002-6138-8112, Gras, L., Koster, L. et al. (43 more authors) (2024) Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: a study of the worldwide network for blood and marrow transplantation (WBMT). American Journal of Hematology, 99 (11). pp. 2084-2095. ISSN 0361-8609

Atsuta, Y., Baldomero, H., Neumann, D. et al. (44 more authors) (2024) Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors. Haematologica, 109 (10). ISSN 0390-6078

Baldomero, H., Neumann, D., Hamad, N. et al. (35 more authors) (2024) The role of registries in hematological disorders. Best Practice & Research Clinical Haematology, 37 (2). 101556.

Pagliuca, S., Kulasekararaj, A.G., Eikema, D.-J. et al. (23 more authors) (2024) Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation. Haematologica, 109 (3). ISSN 0390-6078

Devillier, R., Eikema, D.-J., Dufour, C. et al. (21 more authors) (2023) Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT. Haematologica, 108 (9). pp. 2305-2315. ISSN 0390-6078

Rejeski, K., Subklewe, M. orcid.org/0000-0003-3905-0251, Aljurf, M. et al. (34 more authors) (2023) Immune effector cell-associated hematotoxicity (ICAHT): EHA/EBMT consensus grading and best practice recommendations. Blood Journal. 2023020578. ISSN 0006-4971

Chalandon, Y. orcid.org/0000-0001-9341-8104, Sbianchi, G., Gras, L. et al. (22 more authors) (2023) Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: a retrospective study by the chronic malignancies working party of the EBMT. American Journal of Hematology, 98 (1). pp. 112-121. ISSN 0361-8609

Niederwieser, D., Baldomero, H., Bazuaye, N. et al. (33 more authors) (2022) One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica, 107 (5). pp. 1045-1053. ISSN 0390-6078

Proceedings Paper

Mizuno, S., Gras, L., Baaij, L. et al. (42 more authors) (2023) Impact of age on outcome in newly diagnosed multiple myeloma patients undergoing upfront autologous hematopoietic cell transplantation from the worldwide network for blood and marrow transplantation global study. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California. American Society of Hematology , p. 785.

Drozd-Sokołowska, J. orcid.org/0000-0002-4562-6264, Tridello, G., Verheggen, I. orcid.org/0000-0001-7749-5994 et al. (37 more authors) (2020) O104: Tuberculosis after hematopoietic cell transplantation: retrospective study on behalf of the infectious diseases working party EBMT. In: Bone Marrow Transplantation. The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation, 29 Aug - 01 Sep 2020, Virtual. Springer Nature , pp. 110-112.